MedPath

To Study The Effect Of Hingu Churna In Ovulationâ??

Not Applicable
Conditions
Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
Registration Number
CTRI/2022/10/046207
Lead Sponsor
A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Females with irregular and Scanty menses due to anovulatory cycle

2. WHO Group II anovulatory cycles i.e. Normogonadotrophic Hypogonadism, most common of which is PCOD

3. Pre-diagnosed patients of anovulatory cycles

Exclusion Criteria

1. Age less than 18 years and more than 35 years 2. WHO Type I and Type III Anovulatory Disorders 3. Patients with infertility cause other than follicular development 4. Endometriosis 5. Untreated and Uncontrolled Hyper Prolactinemia 6. Hypo and Hyper Gonadotropin, level 7. Uterine Fibroid 8. Ovarian Tumor 9. Any other non-ovarian Causes of abnormality in ovarian follicle Development.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcomes that will be assessed- Ovarian follicle developmentTimepoint: 3 menstrual cycles
Secondary Outcome Measures
NameTimeMethod
There are no secondary outcomes to be measuredTimepoint: Not applicable
© Copyright 2025. All Rights Reserved by MedPath